Merck announces FDA acceptance of New Drug Application for an investigational tablet formulation of the antifungal NOXAFIL® (posaconazole)
Merck is seeking FDA approval of NOXAFIL...
10 April 2013 | By Merck
Merck is seeking FDA approval of NOXAFIL...